CUSIP 43906K100COMHOOKQ3 2025
35 filings · latest Jul 8, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 498.6K | $461.2K |
| 4 | Feb 14, 2024 | Redmile Group, LLC | 13G/A | 1.1% | 1.06M | SEC |
| 5 | Feb 14, 2024 | Baker Bros. Advisors LP | 13G/A | 10.0% | 8.15M | SEC |
| 6 | Feb 14, 2024 | Ecor1 Capital, LLC | 13G/A | 4.8% | 4.60M | SEC |
| 7 | Dec 22, 2023 | Gilead Sciences, Inc. | 13G/A | 19.4% | 18.76M | SEC |
| 8 | Sep 11, 2023 | Fmr LLC | 13G/A | 4.1% | — | SEC |
| 9 | Jun 20, 2023 | Knoll Capital Management, LLC | 13G | 6.8% | 5.52M | SEC |
| 10 | Feb 14, 2023 | Deep Track Capital, LP | 13G/A | 2.4% | 1.24M | SEC |
See the full Schedule 13D/13G history for Hookipa Pharma.
Unlock full history